|
Mar 24
|
BioNTech Full Year 2023 Earnings: Misses Expectations
|
|
Mar 23
|
Earnings Miss: BioNTech SE Missed EPS By 14% And Analysts Are Revising Their Forecasts
|
|
Mar 21
|
BioNTech SE (NASDAQ:BNTX) Q4 2023 Earnings Call Transcript
|
|
Mar 21
|
Q4 2023 BioNTech SE Earnings Call
|
|
Mar 20
|
BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts
|
|
Mar 20
|
BioNTech Touts Its Oncology Shift After Reporting Disappointing Fourth Quarter Financials
|
|
Mar 20
|
BioNTech Se (BNTX) Q4 2023 Earnings Call Transcript
|
|
Mar 20
|
BioNTech expects more than 10 bln eur peak sales from cancer drug pipeline
|
|
Mar 20
|
BioNTech Earnings Miss Estimates. The Stock Falls and Also Drags Moderna Lower.
|
|
Mar 20
|
UPDATE 1-After earnings plunge, BioNTech pins hopes on cancer drug launches
|
|
Mar 20
|
BioNTech slides as earnings plunge amid cancer drug shift
|
|
Mar 20
|
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
|
|
Mar 20
|
After earnings plunge, BioNTech pins hopes on cancer drug launches
|
|
Mar 20
|
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
|
|
Mar 17
|
Autolus Therapeutics plc (NASDAQ:AUTL) Q4 2023 Earnings Call Transcript
|
|
Mar 15
|
Q4 2023 Autolus Therapeutics PLC Earnings Call
|
|
Mar 14
|
Autolus Therapeutics PLC Reports Full Year 2023 Financial Results
|
|
Mar 13
|
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
|
|
Mar 11
|
Moderna, BioNTech Stocks Rise on New mRNA Possibilities
|
|
Mar 11
|
Will Weakness in BioNTech SE's (NASDAQ:BNTX) Stock Prove Temporary Given Strong Fundamentals?
|